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Abstract. Epilepsy is one of the most common chronic diseases of the nervous system in the world, 
which affects both children and adults. 30% of patients with epilepsy are pharmacoresistant.1 Sumepirin 
1 is a novel antiepileptic drug candidate developed in the Scientific and Educational Center of 
Pharmaceutics of the Kazan Federal University and having pronounced antiseizure effect and improved 
safety profile. This compound is pyridoxine-based molecule with residue of methanesulfonic acid in the 
6th position of pyridoxine ring. 
 
It has successfully passed preclinical studies in the framework of State program of Russian 
Federation “Development of the Pharmaceutical and Medical Industry” and is planned to undergo the 
clinical trials. As Sumepirin entered preclinical studies stage an urgent need of the optimization of its 
method of synthesis arised. As a result of synthetic rout optimization the final synthetic scheme was 
obtained (Scheme 1). 
 
Scheme 1. Reagents and conditions: (a) (CH3)2CO, HCl, 0 °C, 12 h2; (b) CH2O, NaOH, H2O,  
70 °C, 6 h; (c) Na2SO3, H2O, pH = 8.0-9.0, reflux, 5 h; (d) HCl, pH = 1.0, r.t., 0.5 h; (e) NaOH, H2O, r.t., 0.1 h. 
 
Total yield of the final method of synthesis Sumepirin 1 starting prom pyridoxine hydrochloride 
was increased from up to 62.5 % in four steps without colon chromatography purification which allows 
to obtain the target compound with purity of 99.5+% which is especially important for the active 
ingredient. The method is environment-friendly: at first step reagent (acetone) is used as a solvent and any 
other step is carried out in water media; good level of atom economy was achieved. 
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